Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
Buy
60
EDOC Quote, Financials, Valuation and Earnings
Last price:
$10.05
Seasonality move
:
-4.93%
Day range:
$9.80 - $10.23
52-week range:
$8.41 - $10.65
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
11.5K
Avg. volume:
22.4K
1-year change:
0.69%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
EDOC
Global X Telemedicine & Digital Health ETF
|
-- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | -- | -- | -- | -- |
|
GNOM
Global X Genomics & Biotechnology ETF
|
-- | -- | -- | -- | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | -- | -- | -- | -- |
|
IBRN
iShares Neuroscience and Healthcare ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
EDOC
Global X Telemedicine & Digital Health ETF
|
$10.22 | -- | -- | -- | $0.00 | 0% | -- |
|
AGNG
Global X Aging Population ETF
|
$30.75 | -- | -- | -- | $0.10 | 0.74% | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
$61.24 | -- | -- | -- | $0.00 | 0% | -- |
|
GNOM
Global X Genomics & Biotechnology ETF
|
$9.98 | -- | -- | -- | $0.00 | 0% | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
$29.39 | -- | -- | -- | $0.00 | 0% | -- |
|
IBRN
iShares Neuroscience and Healthcare ETF
|
$25.73 | -- | -- | -- | $0.10 | 0.39% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
EDOC
Global X Telemedicine & Digital Health ETF
|
-- | 1.935 | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | 1.009 | -- | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | 1.316 | -- | -- |
|
GNOM
Global X Genomics & Biotechnology ETF
|
-- | 2.318 | -- | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | 1.788 | -- | -- |
|
IBRN
iShares Neuroscience and Healthcare ETF
|
-- | 1.113 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
EDOC
Global X Telemedicine & Digital Health ETF
|
-- | -- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | -- | -- | -- | -- | -- |
|
GNOM
Global X Genomics & Biotechnology ETF
|
-- | -- | -- | -- | -- | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | -- | -- | -- | -- | -- |
|
IBRN
iShares Neuroscience and Healthcare ETF
|
-- | -- | -- | -- | -- | -- |
Global X Telemedicine & Digital Health ETF vs. Competitors
-
Which has Higher Returns EDOC or AGNG?
Global X Aging Population ETF has a net margin of -- compared to Global X Telemedicine & Digital Health ETF's net margin of --. Global X Telemedicine & Digital Health ETF's return on equity of -- beat Global X Aging Population ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital EDOCGlobal X Telemedicine & Digital Health ETF-- -- -- AGNGGlobal X Aging Population ETF-- -- -- -
What do Analysts Say About EDOC or AGNG?
Global X Telemedicine & Digital Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Aging Population ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Global X Telemedicine & Digital Health ETF has higher upside potential than Global X Aging Population ETF, analysts believe Global X Telemedicine & Digital Health ETF is more attractive than Global X Aging Population ETF.
Company Buy Ratings Hold Ratings Sell Ratings EDOCGlobal X Telemedicine & Digital Health ETF0 0 0 AGNGGlobal X Aging Population ETF0 0 0 -
Is EDOC or AGNG More Risky?
Global X Telemedicine & Digital Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Global X Aging Population ETF has a beta of 0.771, suggesting its less volatile than the S&P 500 by 22.927%.
-
Which is a Better Dividend Stock EDOC or AGNG?
Global X Telemedicine & Digital Health ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Global X Aging Population ETF offers a yield of 0.74% to investors and pays a quarterly dividend of $0.10 per share. Global X Telemedicine & Digital Health ETF pays -- of its earnings as a dividend. Global X Aging Population ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios EDOC or AGNG?
Global X Telemedicine & Digital Health ETF quarterly revenues are --, which are smaller than Global X Aging Population ETF quarterly revenues of --. Global X Telemedicine & Digital Health ETF's net income of -- is lower than Global X Aging Population ETF's net income of --. Notably, Global X Telemedicine & Digital Health ETF's price-to-earnings ratio is -- while Global X Aging Population ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global X Telemedicine & Digital Health ETF is -- versus -- for Global X Aging Population ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income EDOCGlobal X Telemedicine & Digital Health ETF-- -- -- -- AGNGGlobal X Aging Population ETF-- -- -- --
-
Which has Higher Returns EDOC or BBP?
Virtus LifeSci Biotech Products ETF has a net margin of -- compared to Global X Telemedicine & Digital Health ETF's net margin of --. Global X Telemedicine & Digital Health ETF's return on equity of -- beat Virtus LifeSci Biotech Products ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital EDOCGlobal X Telemedicine & Digital Health ETF-- -- -- BBPVirtus LifeSci Biotech Products ETF-- -- -- -
What do Analysts Say About EDOC or BBP?
Global X Telemedicine & Digital Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Virtus LifeSci Biotech Products ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Global X Telemedicine & Digital Health ETF has higher upside potential than Virtus LifeSci Biotech Products ETF, analysts believe Global X Telemedicine & Digital Health ETF is more attractive than Virtus LifeSci Biotech Products ETF.
Company Buy Ratings Hold Ratings Sell Ratings EDOCGlobal X Telemedicine & Digital Health ETF0 0 0 BBPVirtus LifeSci Biotech Products ETF0 0 0 -
Is EDOC or BBP More Risky?
Global X Telemedicine & Digital Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Virtus LifeSci Biotech Products ETF has a beta of 0.627, suggesting its less volatile than the S&P 500 by 37.32%.
-
Which is a Better Dividend Stock EDOC or BBP?
Global X Telemedicine & Digital Health ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Virtus LifeSci Biotech Products ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Global X Telemedicine & Digital Health ETF pays -- of its earnings as a dividend. Virtus LifeSci Biotech Products ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios EDOC or BBP?
Global X Telemedicine & Digital Health ETF quarterly revenues are --, which are smaller than Virtus LifeSci Biotech Products ETF quarterly revenues of --. Global X Telemedicine & Digital Health ETF's net income of -- is lower than Virtus LifeSci Biotech Products ETF's net income of --. Notably, Global X Telemedicine & Digital Health ETF's price-to-earnings ratio is -- while Virtus LifeSci Biotech Products ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global X Telemedicine & Digital Health ETF is -- versus -- for Virtus LifeSci Biotech Products ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income EDOCGlobal X Telemedicine & Digital Health ETF-- -- -- -- BBPVirtus LifeSci Biotech Products ETF-- -- -- --
-
Which has Higher Returns EDOC or GNOM?
Global X Genomics & Biotechnology ETF has a net margin of -- compared to Global X Telemedicine & Digital Health ETF's net margin of --. Global X Telemedicine & Digital Health ETF's return on equity of -- beat Global X Genomics & Biotechnology ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital EDOCGlobal X Telemedicine & Digital Health ETF-- -- -- GNOMGlobal X Genomics & Biotechnology ETF-- -- -- -
What do Analysts Say About EDOC or GNOM?
Global X Telemedicine & Digital Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Genomics & Biotechnology ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Global X Telemedicine & Digital Health ETF has higher upside potential than Global X Genomics & Biotechnology ETF, analysts believe Global X Telemedicine & Digital Health ETF is more attractive than Global X Genomics & Biotechnology ETF.
Company Buy Ratings Hold Ratings Sell Ratings EDOCGlobal X Telemedicine & Digital Health ETF0 0 0 GNOMGlobal X Genomics & Biotechnology ETF0 0 0 -
Is EDOC or GNOM More Risky?
Global X Telemedicine & Digital Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Global X Genomics & Biotechnology ETF has a beta of 1.125, suggesting its more volatile than the S&P 500 by 12.532%.
-
Which is a Better Dividend Stock EDOC or GNOM?
Global X Telemedicine & Digital Health ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Global X Genomics & Biotechnology ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Global X Telemedicine & Digital Health ETF pays -- of its earnings as a dividend. Global X Genomics & Biotechnology ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios EDOC or GNOM?
Global X Telemedicine & Digital Health ETF quarterly revenues are --, which are smaller than Global X Genomics & Biotechnology ETF quarterly revenues of --. Global X Telemedicine & Digital Health ETF's net income of -- is lower than Global X Genomics & Biotechnology ETF's net income of --. Notably, Global X Telemedicine & Digital Health ETF's price-to-earnings ratio is -- while Global X Genomics & Biotechnology ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global X Telemedicine & Digital Health ETF is -- versus -- for Global X Genomics & Biotechnology ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income EDOCGlobal X Telemedicine & Digital Health ETF-- -- -- -- GNOMGlobal X Genomics & Biotechnology ETF-- -- -- --
-
Which has Higher Returns EDOC or HTEC?
ROBO Global Healthcare Technology & Innovation ETF has a net margin of -- compared to Global X Telemedicine & Digital Health ETF's net margin of --. Global X Telemedicine & Digital Health ETF's return on equity of -- beat ROBO Global Healthcare Technology & Innovation ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital EDOCGlobal X Telemedicine & Digital Health ETF-- -- -- HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- -
What do Analysts Say About EDOC or HTEC?
Global X Telemedicine & Digital Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand ROBO Global Healthcare Technology & Innovation ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Global X Telemedicine & Digital Health ETF has higher upside potential than ROBO Global Healthcare Technology & Innovation ETF, analysts believe Global X Telemedicine & Digital Health ETF is more attractive than ROBO Global Healthcare Technology & Innovation ETF.
Company Buy Ratings Hold Ratings Sell Ratings EDOCGlobal X Telemedicine & Digital Health ETF0 0 0 HTECROBO Global Healthcare Technology & Innovation ETF0 0 0 -
Is EDOC or HTEC More Risky?
Global X Telemedicine & Digital Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison ROBO Global Healthcare Technology & Innovation ETF has a beta of 1.070, suggesting its more volatile than the S&P 500 by 6.985%.
-
Which is a Better Dividend Stock EDOC or HTEC?
Global X Telemedicine & Digital Health ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ROBO Global Healthcare Technology & Innovation ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Global X Telemedicine & Digital Health ETF pays -- of its earnings as a dividend. ROBO Global Healthcare Technology & Innovation ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios EDOC or HTEC?
Global X Telemedicine & Digital Health ETF quarterly revenues are --, which are smaller than ROBO Global Healthcare Technology & Innovation ETF quarterly revenues of --. Global X Telemedicine & Digital Health ETF's net income of -- is lower than ROBO Global Healthcare Technology & Innovation ETF's net income of --. Notably, Global X Telemedicine & Digital Health ETF's price-to-earnings ratio is -- while ROBO Global Healthcare Technology & Innovation ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global X Telemedicine & Digital Health ETF is -- versus -- for ROBO Global Healthcare Technology & Innovation ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income EDOCGlobal X Telemedicine & Digital Health ETF-- -- -- -- HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- --
-
Which has Higher Returns EDOC or IBRN?
iShares Neuroscience and Healthcare ETF has a net margin of -- compared to Global X Telemedicine & Digital Health ETF's net margin of --. Global X Telemedicine & Digital Health ETF's return on equity of -- beat iShares Neuroscience and Healthcare ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital EDOCGlobal X Telemedicine & Digital Health ETF-- -- -- IBRNiShares Neuroscience and Healthcare ETF-- -- -- -
What do Analysts Say About EDOC or IBRN?
Global X Telemedicine & Digital Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Neuroscience and Healthcare ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Global X Telemedicine & Digital Health ETF has higher upside potential than iShares Neuroscience and Healthcare ETF, analysts believe Global X Telemedicine & Digital Health ETF is more attractive than iShares Neuroscience and Healthcare ETF.
Company Buy Ratings Hold Ratings Sell Ratings EDOCGlobal X Telemedicine & Digital Health ETF0 0 0 IBRNiShares Neuroscience and Healthcare ETF0 0 0 -
Is EDOC or IBRN More Risky?
Global X Telemedicine & Digital Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison iShares Neuroscience and Healthcare ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock EDOC or IBRN?
Global X Telemedicine & Digital Health ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. iShares Neuroscience and Healthcare ETF offers a yield of 0.39% to investors and pays a quarterly dividend of $0.10 per share. Global X Telemedicine & Digital Health ETF pays -- of its earnings as a dividend. iShares Neuroscience and Healthcare ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios EDOC or IBRN?
Global X Telemedicine & Digital Health ETF quarterly revenues are --, which are smaller than iShares Neuroscience and Healthcare ETF quarterly revenues of --. Global X Telemedicine & Digital Health ETF's net income of -- is lower than iShares Neuroscience and Healthcare ETF's net income of --. Notably, Global X Telemedicine & Digital Health ETF's price-to-earnings ratio is -- while iShares Neuroscience and Healthcare ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global X Telemedicine & Digital Health ETF is -- versus -- for iShares Neuroscience and Healthcare ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income EDOCGlobal X Telemedicine & Digital Health ETF-- -- -- -- IBRNiShares Neuroscience and Healthcare ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 43x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
57
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
64
ARQQ alert for Dec 27
Arqit Quantum [ARQQ] is down 6.11% over the past day.
Buy
64
QMCO alert for Dec 27
Quantum [QMCO] is up 0.46% over the past day.
Buy
65
ALGS alert for Dec 27
Aligos Therapeutics [ALGS] is down 4.24% over the past day.
